Document Detail

Electroconvulsive therapy and ocular dystonia.
MedLine Citation:
PMID:  17804995     Owner:  NLM     Status:  MEDLINE    
Electroconvulsive therapy (ECT) has been reported to be beneficial in various movement disorders, especially tardive dystonic reactions. In this article, we report an interesting case of drug-induced blepharospasm with ocular dystonia which improved with ECT. To our knowledge, a case of ocular dystonia improving with ECT has not been previously reported in the literature.
Ashish Sharma; Sharon Hammer; Matthew Egbert; James H Sorrell
Related Documents :
23828035 - Case manager as therapy extender for cognitive behavior therapy of serious mental illne...
21607155 - Granulocytic sarcoma of the rectum: report of one case that presented with rectal bleed...
22195335 - Endometrioid adenocarcinoma arising from endometriosis: a case report.
20303445 - Bifidobacterium septicemia associated with postoperative probiotic therapy in a neonate...
12077525 - Multiple congenital symmetric skin dimples.
509825 - Bilateral sacroilac dislocations in an adolescent. a case report.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The journal of ECT     Volume:  23     ISSN:  1095-0680     ISO Abbreviation:  J ECT     Publication Date:  2007 Sep 
Date Detail:
Created Date:  2007-09-06     Completed Date:  2008-03-07     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9808943     Medline TA:  J ECT     Country:  United States    
Other Details:
Languages:  eng     Pagination:  181-2     Citation Subset:  IM    
Department of Psychiatry, University of Nebraska Medical Center, Omaha, NE 68131-8470, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antipsychotic Agents / adverse effects,  therapeutic use
Bipolar Disorder / complications,  therapy
Blepharospasm / chemically induced,  therapy*
Botulinum Toxin Type A / therapeutic use
Dystonia / complications,  therapy*
Electroconvulsive Therapy*
Remission Induction
Treatment Outcome
Reg. No./Substance:
0/Antipsychotic Agents; 0/Botulinum Toxin Type A

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Electroconvulsive therapy in patients with multiple sclerosis.
Next Document:  Acute and maintenance electroconvulsive therapy for treatment of psychotic depression in a pregnant ...